68083-248-01 |
68083-248 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTION, SOLUTION |
INTRAVENOUS |
20170822 |
N/A |
ANDA |
ANDA209825 |
Gland Pharma Limited |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (68083-248-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
68083-249-01 |
68083-249 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTION, SOLUTION |
INTRAVENOUS |
20170822 |
N/A |
ANDA |
ANDA209825 |
Gland Pharma Limited |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (68083-249-01) / 25 mL in 1 VIAL, SINGLE-DOSE |
68083-250-01 |
68083-250 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTION, SOLUTION |
INTRAVENOUS |
20170822 |
N/A |
ANDA |
ANDA209825 |
Gland Pharma Limited |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, MULTI-DOSE in 1 CARTON (68083-250-01) / 100 mL in 1 VIAL, MULTI-DOSE |
25021-207-25 |
25021-207 |
HUMAN PRESCRIPTION DRUG |
doxorubicin hydrochloride |
doxorubicin hydrochloride |
INJECTION, SOLUTION |
INTRAVENOUS |
20131031 |
N/A |
ANDA |
ANDA209825 |
Sagent Pharmaceuticals |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL in 1 CARTON (25021-207-25) / 25 mL in 1 VIAL |
25021-207-51 |
25021-207 |
HUMAN PRESCRIPTION DRUG |
doxorubicin hydrochloride |
doxorubicin hydrochloride |
INJECTION, SOLUTION |
INTRAVENOUS |
20131031 |
N/A |
ANDA |
ANDA209825 |
Sagent Pharmaceuticals |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL in 1 CARTON (25021-207-51) / 100 mL in 1 VIAL |